News

Women whose breasts are composed largely of glandular tissue, rather than fat, have an amplified risk of breast cancer, which exceeds the impact of other widely known risks on a population level, including family history of the disease, personal history of benign lesions and first full-term

E-cigarettes – thought by some to be responsible for a decline in youth cigarette smoking – are actually attracting a new population of adolescents who might not otherwise have smoked tobacco products, according to a new UC San Francisco study. In the first national analysis of the impact of e

New research led by researchers from UC San Francisco and Stanford University has found that successful cancer immunotherapy appears to depend on whether the treatment can trigger a system-wide immune response, rather than just a local response within the tumor itself. Specifically, data from both

With catchy names like Smurf Cake and Unicorn Puke and sweet flavors like bubble gum and strawberry, electronic cigarettes may have special appeal to young people, but that doesn’t mean they are safe. Evidence is mounting that e-cigarettes are exposing a new generation to nicotine addiction and may

To honor and build on a lifetime of giving and charitable service by the late Helen Diller, the Helen Diller Foundation has granted $500 million to UC San Francisco, a university to which Helen was both generous and devoted. The gift will be the largest single donation in UCSF’s history and one of

Recognizing a critical need to improve national vaccination rates for the human papillomavirus (HPV), the UCSF Helen Diller Family Comprehensive Cancer Center has again united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement in support of

UC San Francisco and Pfizer Inc.’s Centers for Therapeutic Innovation (CTI) have renewed an agreement to identify and develop biologic compounds against both known and novel targets, including the immune system, in diseases such as cancer, cardiovascular and metabolic diseases. The collaboration